IONS vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

IONS

59.4
AI Score
VS
IONS Wins

BBIO

55.7
AI Score

Investment Advisor Scores

IONS

59score
Recommendation
HOLD

BBIO

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IONS BBIO Winner
Forward P/E 90.9091 0 Tie
PEG Ratio 25.7033 0 Tie
Revenue Growth -40.7% 66.8% BBIO
Earnings Growth -43.7% 0.0% BBIO
Tradestie Score 59.4/100 55.7/100 IONS
Profit Margin -64.7% -124.4% IONS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IONS 1M: -34.6% · 3M: -30.8% BBIO 1M: +7.5% · 3M: +12.6%

Current Technical Phase

IONS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.0%), weak momentum, RSI 26

RSI (14): 26.4 · Price: $51.77

BBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.8% over 20 days), RSI 51

RSI (14): 50.8 · Price: $80.09

Fundamentals Snapshot

Metric IONS BBIO
Market Cap
Forward P/E -34.1 140.8
Trailing P/E
Revenue (TTM)
Revenue Growth -0.4% 0.7%
Gross Margin -0.1% 1.0%
Operating Margin -0.4% -0.5%
EPS -3.43 -3.67
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IONS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.